167 related articles for article (PubMed ID: 27838564)
1. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010.
Jespersen CG; Nørgaard M; Borre M
Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564
[TBL] [Abstract][Full Text] [Related]
2. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
[TBL] [Abstract][Full Text] [Related]
4. Association between Parkinson's disease and risk of prostate cancer in different populations: An updated meta-analysis.
Chen C; Zheng H; Hu Z
Sci Rep; 2017 Oct; 7(1):13449. PubMed ID: 29044216
[TBL] [Abstract][Full Text] [Related]
5. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
6. Use of vitamin K antagonists and risk of prostate cancer: Meta-analysis and nationwide case-control study.
Kristensen KB; Jensen PH; Skriver C; Friis S; Pottegård A
Int J Cancer; 2019 Apr; 144(7):1522-1529. PubMed ID: 30246248
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and colorectal cancer risk-A nested case control study.
Boursi B; Mamtani R; Haynes K; Yang YX
Cancer Epidemiol; 2016 Aug; 43():9-14. PubMed ID: 27232063
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and Parkinson's disease risk in Danish women.
Greene N; Lassen CF; Rugbjerg K; Ritz B
Eur J Neurol; 2014 Sep; 21(9):1168-77, e68. PubMed ID: 24750445
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
Eur J Clin Pharmacol; 2018 Jan; 74(1):99-107. PubMed ID: 28967041
[TBL] [Abstract][Full Text] [Related]
10. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
Rugbjerg K; Friis S; Lassen CF; Ritz B; Olsen JH
Int J Cancer; 2012 Oct; 131(8):1904-11. PubMed ID: 22278152
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and the risk of developing Parkinson's disease in Denmark.
Schernhammer E; Hansen J; Rugbjerg K; Wermuth L; Ritz B
Diabetes Care; 2011 May; 34(5):1102-8. PubMed ID: 21411503
[TBL] [Abstract][Full Text] [Related]
14. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
Mokhles MM; Trifirò G; Dieleman JP; Haag MD; van Soest EM; Verhamme KM; Mazzaglia G; Herings R; Luise Cd; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; Camp Gv; Zanettini R; Sturkenboom MC
Pharmacol Res; 2012 Mar; 65(3):358-64. PubMed ID: 22123498
[TBL] [Abstract][Full Text] [Related]
15. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.
Dick FD; De Palma G; Ahmadi A; Scott NW; Prescott GJ; Bennett J; Semple S; Dick S; Counsell C; Mozzoni P; Haites N; Wettinger SB; Mutti A; Otelea M; Seaton A; Söderkvist P; Felice A;
Occup Environ Med; 2007 Oct; 64(10):666-72. PubMed ID: 17332139
[TBL] [Abstract][Full Text] [Related]
16. Early life risk factors for prostate cancer: a population-based case-control study in Sweden.
Andersson SO; Baron J; Wolk A; Lindgren C; Bergström R; Adami HO
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):187-92. PubMed ID: 7606192
[TBL] [Abstract][Full Text] [Related]
17. Traffic-Related Air Pollution and Parkinson's Disease in Denmark: A Case-Control Study.
Ritz B; Lee PC; Hansen J; Lassen CF; Ketzel M; Sørensen M; Raaschou-Nielsen O
Environ Health Perspect; 2016 Mar; 124(3):351-6. PubMed ID: 26151951
[TBL] [Abstract][Full Text] [Related]
18. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer.
Chung SD; Lin HC; Tsai MC; Kao LT; Huang CY; Chen KC
Andrology; 2016 May; 4(3):481-5. PubMed ID: 27062333
[TBL] [Abstract][Full Text] [Related]
20. History of diabetes mellitus and risk of prostate cancer in physicians.
Zhu K; Lee IM; Sesso HD; Buring JE; Levine RS; Gaziano JM
Am J Epidemiol; 2004 May; 159(10):978-82. PubMed ID: 15128610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
